Page 70 - IJB-10-6
P. 70
International Journal of Bioprinting Semi-solid extrusion for pediatric medicine
advanced drug delivery and medical device applications. printing process and printer design. Ther Innov Regul Sci.
J Controlled Release. 2021;329:743-757. 2022;56(6):910-928.
doi: 10.1016/j.jconrel.2020.10.008 doi: 10.1007/s43441-021-00354-0
67. Uddin MJ, Hassan J, Douroumis D. Thermal inkjet printing: 78. Tagami T, Yoshimura N, Goto E, Noda T, Ozeki T.
prospects and applications in the development of medicine. Fabrication of muco-adhesive oral films by the 3D
Technologies. 2022;10(5):108. printing of hydroxypropyl methylcellulose-based catechin-
doi: 10.3390/technologies10050108 loaded formulations. Biol Pharm Bull. 2019;42(11):
68. Carou-Senra P, Rodríguez-Pombo L, Awad A, Basit 1898-1905.
AW, Alvarez-Lorenzo C, Goyanes A. Inkjet printing of doi: 10.1248/bpb.b19-00481
pharmaceuticals. Adv Mater. 2024;36(11):2309164. 79. Parulski C, Bya LA, Goebel J, Servais AC, Lechanteur A,
doi: 10.1002/adma.202309164 Evrard B. Development of 3D printed mini-waffle shapes
69. Académie de Pharmacie. Dictionnaire de l’académie de containing hydrocortisone for children’s personalized
Pharmacie. medicine. Int J Pharm. 2023;642:123131.
https://dictionnaire.acadpharm.org/w/Extrusion doi: 10.1016/j.ijpharm.2023.123131
70. Cailleaux S, Sanchez-Ballester NM, Gueche YA, Bataille B, 80. Seoane-Viaño I, Januskaite P, Alvarez-Lorenzo C, Basit AW,
Soulairol I. Fused Deposition Modeling (FDM), the new Goyanes A. Semi-solid extrusion 3D printing in drug delivery
asset for the production of tailored medicines. J Controlled and biomedicine: personalised solutions for healthcare
Release. 2021;330:821-841. challenges. J Controlled Release. 2021;332:367-389.
doi: 10.1016/j.jconrel.2020.10.056 doi: 10.1016/j.jconrel.2021.02.027
71. Cano-Vicent A, Tambuwala MM, Hassan SkS, et al. Fused 81. Díaz-Torres E, Rodríguez-Pombo L, Ong JJ, et al. Integrating
deposition modelling: Current status, methodology, pressure sensor control into semi-solid extrusion 3D
applications and future prospects. Addit Manuf. printing to optimize medicine manufacturing. Int J Pharm
2021;47:102378. X. 2022;4:100133.
doi: 10.1016/j.addma.2021.102378 doi: 10.1016/j.ijpx.2022.100133
72. Eleftheriadis GK, Ritzoulis C, Bouropoulos N, et al. 82. Roche A, Sanchez-Ballester NM, Aubert A, Rossi JC,
Unidirectional drug release from 3D printed mucoadhesive Begu S, Soulairol I. Preliminary Study on the development
buccal films using FDM technology: in vitro and ex vivo of caffeine oral solid form 3D printed by semi-solid
evaluation. Eur J Pharm Biopharm. 2019;144:180-192. extrusion for application in neonates. AAPS PharmSciTech.
doi: 10.1016/j.ejpb.2019.09.018 2023;24(5):122.
doi: 10.1208/s12249-023-02582-z
73. Goyanes A, Allahham N, Trenfield SJ, Stoyanov E, Gaisford S,
Basit AW. Direct powder extrusion 3D printing: Fabrication 83. Koshovyi O, Vlasova I, Laur H, et al. Chemical composition
of drug products using a novel single-step process. and insulin-resistance activity of arginine-loaded american
Int J Pharm. 2019;567:118471. cranberry (Vaccinium macrocarpon Aiton, Ericaceae) Leaf
doi: 10.1016/j.ijpharm.2019.118471 Extracts. Pharmaceutics. 2023;15(11):2528.
doi: 10.3390/pharmaceutics15112528
74. Isreb A, Baj K, Wojsz M, Isreb M, Peak M, Alhnan MA. 3D
printed oral theophylline doses with innovative ‘radiator- 84. Lyousoufi M, Lafeber I, Kweekel D, et al. Development
like’ design: Impact of polyethylene oxide (PEO) molecular and bioequivalence of 3D-printed medication at the point-
weight. Int J Pharm. 2019;564:98-105. of-care: bridging the gap toward personalized medicine.
doi: 10.1016/j.ijpharm.2019.04.017 Clin Pharmacol Ther. 2023;113(5):1125-1131.
doi: 10.1002/cpt.2870
75. Nober C, Manini G, Carlier E, et al. Feasibility study into the
potential use of fused-deposition modeling to manufacture 85. Chatzitaki AT, Eleftheriadis G, Tsongas K, et al. Fabrication
3D-printed enteric capsules in compounding pharmacies. of 3D-printed octreotide acetate-loaded oral solid
Int J Pharm. 2019;569:118581. dosage forms by means of semi-solid extrusion printing.
doi: 10.1016/j.ijpharm.2019.118581 Int J Pharm. 2023;632:122569.
doi: 10.1016/j.ijpharm.2022.122569
76. Parulski C, Jennotte O, Lechanteur A, Evrard B. Challenges
of fused deposition modeling 3D printing in pharmaceutical 86. Teoh XY, Zhang B, Belton P, Chan SY, Qi S. The effects of
applications: where are we now? Adv Drug Deliv Rev. solid particle containing inks on the printing quality of
2021;175:113810. porous pharmaceutical structures fabricated by 3d semi-
doi: 10.1016/j.addr.2021.05.020 solid extrusion printing. Pharm Res. 2022;39(6):1267-1279.
doi: 10.1007/s11095-022-03299-7
77. Quodbach J, Bogdahn M, Breitkreutz J, et al. Quality of
FDM 3D printed medicines for pediatrics: considerations 87. de Oliveira TV, de Oliveira RS, dos Santos J, Funk NL,
for formulation development, filament extrusion, Petzhold CL, Beck RCR. Redispersible 3D printed
Volume 10 Issue 6 (2024) 62 doi: 10.36922/ijb.4063

